November 2019

UROLOGY

THE LINK BETWEEN PROSTATE CANCER AND INFLAMMATORY BOWEL DISEASE

Featuring: Shilajit D. Kundu, MD

Episode Summary

Men with inflammatory bowel disease have four to five times higher risk of being diagnosed with prostate cancer, according to a 20-year study from Northwestern Medicine published in the journal European Urology.

Shilajit D. Kundu, MD, chief of urologic oncology and associate professor in the Division of Urology at Northwestern Medicine and a member of Robert H. Lurie Comprehensive Cancer Center of Northwestern University, discusses the link between prostate cancer and inflammatory bowel disease. Dr. Kundu shares Northwestern Medicine's approach to screening, diagnosing and treating this unique combination of conditions. 
Shilajit D. Kundu, MD, chief of urologic oncology and associate professor in the Division of Urology at Northwestern Medicine and a member of Robert H. Lurie Comprehensive Cancer Center of Northwestern University.

Refer a Patient

Northwestern Medicine welcomes the opportunity to partner with you in caring for your patients. ​

You May Also Like